Gilead Sciences : Cramer’s bullish on Gilead for its AIDS drugs, saying that he thinks AIDS will be a focus for the Obama administration. Under $50, GILD is a buy.
Skechers U.S.A. : Cramer said he’s not a fan of Skechers. He’s going to wait for Nike to report its quarter earnings and then decide whether or not NKE is a buy.
Principal Financial : Negative comments from a Goldman Sachs analyst scared Cramer and a lot of other investors out of this stock. Cramer wants a progress report from that analyst before he changes his mind about PFG. Because if the situation’s still bad, investors might want to take profits with the stock up $3 Tuesday.